Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 44 for “"SLC7A11"”.
-
Regulation of the Amino Acid Exchanger xCT (Slc7a11) in Acute Pancreatitis
… up regulation of the cystine transporter xCT (Slc7a11) mRNA was observed. Moreover, this mRNA increase led to enhanced xCT protein levels, which was quantified by Western blot analysis. During acute pancreatitis, the up regulated transporter xCT was localised to the acinar cell membrane via …
-
OVEREXPRESSION OF SLC38A2 AND SLC7A11 TRANSPORTER GENES IN CHO-S CELLS TO INCREASE TRANSPORT OF GLUTAMINE AND GLUTAMATE
… genes like SLC38A2, SLC38A3, SLC1A5 and SLC7A11 in CHO-S to reveal the impact of overexpression of those transporter genes in CHO-S cells. This research revealed that overexpression of SLC38A2 transporter gene in CHO-S cells could help cells uptake more glutamine in both GlutaMAX (AQ) and …
-
Inhibition of the Cystine-Glutamate Transporter SLC7A11 increases sensitivity to Platinum-based drugs in Non-Small Cell Lung Cancer
… (ROS). Solute Carrier Family 7 Member 11 (SLC7A11) is a key regulator of amino acid metabolism and is highly expressed in NSCLC cells. SLC7A11 helps protects cancer cells from chemotherapy-induced ROS by promoting glutathione synthesis to stabilise ROS. We hypothesised that inhibiting …
-
The role of Slc7a11 in controlling extracellular and intracellular redox environments of lung fibroblasts - potential targets for intervention in aging and idiopathic pulmonary fibrosis.
… young mice. Microarray shows down-regulation of Slc7a11 potentially mediates this age-related oxidation. Slc7a11 is the key component of system Xc-, an antiporter that imports CySS and exports glutamate. The first aim of this dissertation is to investigate the mechanistic link between Slc7a11 …
-
Investigating Therapeutic Strategies to Target Metabolic Vulnerabilities of Nsclc Tumors With Mutant Keap1 Gene
… bestowed by KEAP1/NRF2 signaling axis through SLC7A11. SLC7A11 is a transcriptional target of NRF2, an essential regulator of cellular anti-oxidant response. Under unstressed basal conditions, NRF2 interacts with KEAP1, a tumor suppressor gene and a substrate adaptor protein of the …
-
Genetic factors that determine host resistance to bacterial infection
… of U937 cells and examines the role the gene SLC7A11 plays in the infection process a previous work identified that SLC7A11 gene mutations decreased susceptibility to infection. SLC7A11 CRISPR #1 U937 cells were infected with Salmonella enterica serovar typhimurium to help understand if this …
-
Optimising CAR-T cells for enhanced activity in the tumour microenvironment
… tryptophan or cystine transporters, SLC7A5 and SLC7A11, respectively. We first demonstrated that the addition of SLC7A5 and SLC7A11 to Jurkat CAR T-cells provided increased metabolic rates in low tryptophan and cystine environments, respectively. The addition of SLC7A5 and SLC7A11 to CAR T-cells …
-
Metabolically rewiring pancreatic stromal cells in pancreatic cancer
… particularly solute carrier transporter 7A11 (SLC7A11) and solute carrier transporter 7A5 (SLC7A5), which are upregulated in PC cells and CA-PSCs. This study aimed: (1) to assess SLC7A11 inhibition in cancer-associated pancreatic stellate cells in vitro and in a clinically relevant orthotopic …
-
Modulation of the NRF2 Regulatory Network by the Glucocorticoid Receptor
… stress pathways. Key NRF2 target genes, such as SLC7A11, were consistently repressed across macrovascular and microvascular endothelial models. SLC7A11 codes for a glutamate-cystine antiporter essential for glutathione synthesis. Dissecting the SLC7A11 locus revealed that GR binds regulatory …
-
Innovative Approaches To Identify Regulators Of Liver Regeneration
… that repopulating hepatocytes highly upregulate Slc7a11, a gene that encodes the cystine/glutamate antiporter. I demonstrated that ectopic Slc7a11 expression promotes liver regeneration and Slc7a11 mutation inhibits hepatocyte replication. Integrative bioinformatics analyses of chromatin …
-
Exploiting Metabolic Vulnerabilities In Solid Tumors Treated With ABL Kinase Allosteric Inhibitors
… axis as ABL inhibition was shown to deplete SLC7A11 protein levels in cancer cells. SLC7A11 is the catalytic subunit of system xCT and enables cystine import for cell detoxification and concomitant glutamate export. By depleting cancer cells of SLC7A11, cell detoxification processes are …
-
PERTURBATION OF ASTROCYTIC KEAP1-NRF2-ARE PATHWAY AND GLUTAMATE TRANSPORTER EXPRESSION IN SPINAL ASTROCYTIC DEGENERATION
… concomitant increase of glutamate transporter Slc7a11 encoded for the system Xc-, and Slc1a3 encoded for EAAT1, and Slc1a2 encoded for EAAT2 expression during MeHg exposure might suggest the cooperative expression or function of these glutamate transporters. This concomitant expression was …
-
Metabolic Reprogramming in Response to Mitochondrial Electron Transport Chain Dysfunction
… and glutamine) from the TCA cycle. Additionally, SLC7A11 (a plasma membrane glutamate/cystine antiporter) promotes pyruvate oxidation in the mitochondria via generation of an electron acceptor, a-ketobutyrate. Furthermore, in the liver, loss of ETC complex I results in no observable clinical or …
-
Optimization of Recombinant Protein Production in Different Cell Lines
… Overexpression of transporter genes SLC38A2 and SLC7A11 is employed to manipulate the glutamine-glutamate metabolic pathway. Comparative experiments confirm that cells overexpressing SLC7A11 and SLC38A exhibit higher glutamate serection compared to those non-transfected cells. These plasmids used …
-
The effect of glutamine absence on the viability of endothelial cells with mTOR knockdown genes
… all the genes tested, endothelial cells with CS, SLC7A11, WDR59, and WDR24 knockdowns were shown to have greater viability in glutamine deficient media than the controls. They were also shown to have suppressed proliferative behavior in complete media. CONCLUSIONS: Despite initial CRISPR screening …
-
Reprogramming Pancreatic Cancer Cells to Surrender to Microenvironmental Death Signals
… explored by our lab: solute carrier 7A11 (SLC7A11) and heat shock protein 47 (HSP47) Here, we identified that silencing βIII-tubulin in pancreatic cancer cells activated extrinsic apoptosis and increased their sensitivity to extrinsic apoptosis inducers including tumour necrosis factor-α …
-
Illuminating the Non-Canonical, Pro-Tumorigenic Role of Hippo Tumor Suppressor Kinase STK3 and Its Mechanism of Action in Prostate Cancer.
… that individual ferroptosis resistance genes SLC7A11 and SLC3A2 had decreased expression with loss of STK3. In Chapter 5, we discuss this transcriptomic data and test the connection between STK3 and these genes using our genetic models, a kinase dead STK3 overexpression model and novel STK3i …
-
In-vitro Analysen der Cysteinrestriktion in murinen und humanen Zelllinien des Multiplen Myeloms sowie im murinen Modellsystem MPC11
… Ein Einfluss auf die Aminosäuretransporter Slc7a11 und Slc1a5 ist allerdings nicht ausgeschlossen. Die Cysteinrestriktion stellte sich in den Proliferationsversuchen effektiver dar als die Methioninrestriktion. Eine vollständige Restriktion der Aminosäuren scheint nicht notwendig zu sein, um …
-
The Solute Transporter xCT and Response to Receptor Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
… Targeted knockdown of the gene encoding xCT, SLC7A11, using shRNA but not pharmacological inhibition with the putative xCT inhibitor sulfasalazine resulted in reduced IC50 in TKI sensitive as well as resistant cells, indicating a drug (re)sensitization. SEC24D, a critical component of the …
Page 1 of 3